Product Image

Visibili-T

LifeSeasons
4.5
★ ★ ★ ★ ★
(664 ratings)
Chromium 400 mcg
Vitamin A 5000 IU
Ginkgo
Lycopene 2 mg
Product Image
Score73
A coherent vision formula with strong lutein, zeaxanthin, bilberry, and ginkgo amounts. Medication interactions from ginkgo and chromium are the main practical limitation.
How scoring works
Quantity:60 Capsule(s) • (30 servings)
Goals:
Vision Support

Score 73

A coherent vision formula with strong lutein, zeaxanthin, bilberry, and ginkgo amounts. Medication interactions from ginkgo and chromium are the main practical limitation.
How scoring works
$38.99($1.29 per serving)
iHerb
$ 38.99
Pure Formulas
$ 38.99
Amazon
$ 38.99
Report prices

Analysis

The two-capsule serving provides 20 mg lutein, 3 mg zeaxanthin, bilberry anthocyanins, grape-seed polyphenols, carrot, and beta-carotene. This combination offers practical coverage for macular pigments and ocular antioxidant support.

Ginkgo is present at 120 mg and may add circulatory support, while chromium is supplied at 400 mcg. Lycopene is modest, and no fat carrier is listed for the carotenoids.

The formula best fits adults seeking vision support who can safely use ginkgo and chromium. Taking it with a meal containing fat may improve carotenoid absorption.

Who is it for
  • Adults seeking targeted macular pigment support
  • People interested in bilberry and ginkgo
  • Users who can safely take chromium and ginkgo
Best for
  • Lutein and zeaxanthin supplementation
  • Broad eye antioxidant support
  • Combining carotenoids with bilberry

Pros

  • Provides 20 mg lutein and 3 mg zeaxanthin
  • Includes standardized bilberry and grape-seed extracts
  • Supplies a meaningful ginkgo amount
  • Offers a coherent vision-focused blend

Cons

  • No fat carrier is disclosed for carotenoids
  • Lycopene amount is modest
  • Premium serving cost
  • Ginkgo and chromium widen interaction concerns

Warnings

  • Ginkgo may increase bleeding tendency with anticoagulant or antiplatelet medicines.
  • Chromium may add to the effect of glucose-lowering medicines and requires monitored use in treated diabetes.
  • Ginkgo may lower seizure threshold and is unsuitable for people with seizure disorders without clinical guidance.

Nutrient quality

81 Highest impact

Meaningful carotenoids and standardized plant extracts create a well-targeted formula. High chromium and an ambiguous ginkgo listing weaken dose balance.

.

Ingredient transparency

73 High impact

Most actives have clear amounts and no proprietary blend hides the formula. Ambiguous ginkgo entries plus missing usage and excipient details prevent full clarity.

.

Customer satisfaction

67 High impact

Aggregate satisfaction is fairly strong and supported by a substantial evidence base. No firsthand experience details are supplied, so recurring complaints and purpose alignment cannot be checked.

.

Value for money

68 High impact

Useful core ingredients provide fair value despite some trade-offs. Clearer or better-dosed alternatives may compare more favorably.

.
Report analysis

Goals

Vision Support
Vision Support
Impact
Highest effect
A Goal FitA- Strength of SupportB CoverageA- Formula Quality
Vitamin A · 5000 IU

Lutein and zeaxanthin are supplied at substantial, clearly stated amounts that directly support macular pigment and internal light filtration. Ginkgo, bilberry, grape seed, and beta-carotene add circulation and antioxidant support, though the formula lacks omega-3s and the full established antioxidant-mineral combination.

The design is strongly aligned with vision support and maintains useful depth across its main actives. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 11 studies
Brain Health
Brain Health
Impact
Moderate effect
C Goal FitB+ Strength of SupportC CoverageD Formula Quality

Ginkgo may support cerebral circulation, but the formula is mainly designed for eye and visual health. The ginkgo amount fits a common daily range.

Carotenoids and eye-focused antioxidants add little direct support for memory or attention, while ginkgo marker percentages are missing. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Cognitive Support
Cognitive Support
Impact
Moderate effect
C Goal FitB+ Strength of SupportC CoverageD Formula Quality

Ginkgo may support cerebral circulation, but the formula is mainly designed for eye and visual health. The ginkgo amount fits a common daily range.

Carotenoids and eye-focused antioxidants add little direct support for memory or attention, while ginkgo marker percentages are missing. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 87 studies
Skin Health
Skin Health
Impact
Moderate effect
C Goal FitC Strength of SupportD+ CoverageD+ Formula Quality
Lycopene · 2 mg

Carotenoids, grape seed, and bilberry provide antioxidant support that may help skin handle environmental stress. The eye-focused formula lacks a structural or hydration active, and the small lycopene amount limits its strongest skin-specific rationale.

Vitamin A is supplied as beta-carotene rather than preformed retinol, which reduces toxicity concern but offers less direct retinoid activity. Ginkgo can increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Lycopene Supportive 20 studies
Vitamin A Supportive 106 studies
Mental Focus
Mental Focus
Impact
Moderate effect
D+ Goal FitB Strength of SupportD CoverageD- Formula Quality

A full ginkgo amount may modestly support attention through cerebral blood flow. The remaining carotenoids and plant antioxidants are aimed primarily at eye health, making mental focus a secondary use.

Both ginkgo marker groups are named and the total amount is clear, but marker percentages and purity limits are absent. Ginkgo may raise bleeding risk when used with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 28 studies

Ingredients

IngredientAmount per serving
Vitamin A (Beta-Carotene)
 5000 IU
Chromium (Chromium Polynicotinate)
 400 mcg
Carrot
150 mg
Ginkgo biloba leaf extract (Flavone Glycosides, Terpene Lactones)
 120 mg
Grape seed extract (Polyphenols)
 100 mg
Bilberry fruit extract (Anthocyanins)
 50 mg
Lutein
20 mg
Zeaxanthin
3 mg
Lycopene
2 mg
Gluten Free Adults 18–50 Dairy Free Vegetarian
Report overview
Chromium (Chromium Polynicotinate) · 400 mcg OverallScore70
B- Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyD- Value

A well-absorbed organic chromium form supports ingredient quality. The 400 mcg amount provides targeted potency, though the label gives only one weight rather than separating elemental chromium from compound weight. Standardized serving value is weak when chromium is the main purchase goal.

View ingredientView products
Vitamin A (Beta-Carotene) · 5000 IU OverallScore64
D+ Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value

Beta-carotene provides a well-regulated source of vitamin A, but the label does not identify whether it comes from a natural source. The 5,000 IU dose is well aligned with routine supplementation. A dry capsule and high cost for the vitamin A provided limit its appeal.

View ingredientView products
Ginkgo (Flavone Glycosides, Terpene Lactones) · 120 mg OverallScore52
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value

The extract lists both major ginkgo marker groups, but missing percentages prevent confirmation of full standardization. Its daily amount falls within the usual clinical range and is clearly disclosed. Bilberry, lutein, and zeaxanthin add relevant eye support, though ginkgo may raise bleeding risk with anticoagulant or antiplatelet medicines.

View ingredientView products
Loading alternative details
70 Performance

Circulari-T Blood

LifeSeasons
<p>Standardized ginkgo, horse chestnut, butcher's broom, grape seed, and gotu kola provide more coherent circulation support with named doses. It lacks lutein and zeaxanthin for the original's main eye goal, and ginkgo may compound bleeding risk with blood-thinning medicines.</p>
72 Performance

Thyroid Synergy

Designs for Health
<p>Chelated chromium, zinc, selenium, copper, active riboflavin, and named botanicals provide stronger ingredient-form disclosure. Its thyroid focus does not replace lutein, zeaxanthin, or bilberry, so it is better formulated but poorly matched to vision support.</p>
78 Budget

One Daily Men's Health

Equate
<p>The very low serving cost provides beta-carotene, chromium, and lycopene within broad daily micronutrient coverage. Most chemical forms are missing and the eye-specific carotenoids are far weaker than in the original.</p>
78 Budget

Eye Wellness With Zeaxanthin

Bio Nutrition
<p>The much lower cost preserves a directly relevant eye core with lutein, zeaxanthin, beta-carotene, bilberry, and ginkgo. Several botanicals are lightly dosed or not standardized, and ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.</p>
71 Budget

Gold

NaturesPlus Source of Life Animal Parade
<p>The lower serving cost supplies beta-carotene, chromium, vitamin K2, methylfolate, and methylcobalamin in a broad chewable. It is a children's formula with only a token lutein amount, so it is not a close adult eye-support substitute.</p>
61 Value

Ginkgo Biloba & Red Panax Ginseng Extract

Prince Of Peace
<p>The lower-cost liquid includes ginkgo and ginseng for circulation and energy support. Neither extract is standardized, the ginkgo amount is modest, and it supplies almost no meaningful vitamin A or eye-specific carotenoids.</p>
56 Value

HCF Happy Calm Focused F&Q Regular Strength

HCF Happy Calm Focused
<p>The formula costs about the same and retains beta-carotene plus chromium polynicotinate with basic vitamins. Its central amino-acid blend is hidden and it omits lutein, zeaxanthin, lycopene, bilberry, and grape seed, making it weaker for the original goal.</p>
59 Value

Choline Cocktail

Twinlab
<p>The high choline amount and standardized ginkgo provide a more focused cognitive formula. High vitamin A and E, added sugar, a much higher serving cost, and no lutein or zeaxanthin make it poor value for vision support.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Vitamin A and fish oils for preventing the progression of retinitis pigmentosa.
    Schwartz SG; Wang X; Chavis P; Kuriyan AE; Abariga SA · The Cochrane database of systematic reviews · 2020
    Systematic review944 participants4 studies pooledVision Support forVitamin A
  2. Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.
    Page JW; Findley J; Crognale MA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006
    Clinical trialVision Support forGinkgo
  3. The Associations of Plasma Carotenoids and Vitamins With Risk of Age-Related Macular Degeneration: Results From a Matched Case-Control Study in China and Meta-Analysis.
    Jiang H; Fan Y; Li J; Wang J; Kong L; Wang L; Li Z; Ma M; Shi X; Liu S; Shi J; Zhu H; Liu X; Ma L · Frontiers in nutrition · 2022
    Meta-analysis9 studies pooledVision Support forLycopene
  4. Vitamin A and fish oils for retinitis pigmentosa.
    Rayapudi S; Schwartz SG; Wang X; Chavis P · The Cochrane database of systematic reviews · 2014
    Systematic review866 participants3 studies pooledVision Support forVitamin A
  5. Ginkgo biloba--an appraisal.
    Dubey AK; Shankar PR; Upadhyaya D; Deshpande VY · Kathmandu University medical journal (KUMJ) · 2007
    Narrative reviewVision Support forGinkgo
  6. Serum carotenoids and risk of age-related macular degeneration in a chinese population sample.
    Zhou H; Zhao X; Johnson EJ; Lim A; Sun E; Yu J; Zhang Y; Liu X; Snellingen T; Shang F; Liu N · Investigative ophthalmology & visual science · 2011
    Case-control study263 participantsVision Support forLycopene
  7. Long-term effects of fenretinide on retinal function.
    Decensi A; Fontana V; Fioretto M; Rondanina G; Torrisi R; Orengo MA; Costa A · European journal of cancer (Oxford, England : 1990) · 1997
    Clinical trial42 participantsVision Support forVitamin A
  8. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  9. Serum antioxidants and age-related macular degeneration in a population-based case-control study.
    Mares-Perlman JA; Brady WE; Klein R; Klein BE; Bowen P; Stacewicz-Sapuntzakis M; Palta M · Archives of ophthalmology (Chicago, Ill. : 1960) · 1995
    Case-control study334 participantsVision Support forLycopene
  10. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.
    Berson EL; Rosner B; Sandberg MA; Hayes KC; Nicholson BW; Weigel-DiFranco C; Willett W · Archives of ophthalmology (Chicago, Ill. : 1960) · 1993
    Randomized trial601 participantsVision Support forVitamin A
  11. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  12. Association between serum carotenoid concentrations and risk of major age-related eye diseases among middle-aged and older adults.
    Che S; Ma Y; Cao J · Frontiers in medicine · 2025
    Cross-sectional study1,478 participantsVision Support forLycopene
  13. Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial.
    Toshida H; Funaki T; Ono K; Tabuchi N; Watanabe S; Seki T; Otake H; Kato T; Ebihara N; Murakami A · Drug design, development and therapy · 2018
    Randomized trial66 participantsVision Support forVitamin A
  14. Ginkgo biloba extract for age-related macular degeneration.
    Evans JR · The Cochrane database of systematic reviews · 2013
    Systematic review119 participants2 studies pooledVision Support forGinkgo
  15. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
    Kim EC; Choi JS; Joo CK · American journal of ophthalmology · 2009
    Randomized trial150 participantsVision Support forVitamin A
  16. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo
  17. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity.
    Mactier H; McCulloch DL; Hamilton R; Galloway P; Bradnam MS; Young D; Lavy T; Farrell L; Weaver LT · The Journal of pediatrics · 2012
    Randomized trial89 participantsVision Support forVitamin A
  18. [Treatment of senile macular degeneration with Ginkgo biloba extract. A preliminary double-blind drug vs. placebo study].
    Lebuisson DA; Leroy L; Rigal G · Presse medicale (Paris, France : 1983) · 1987
    Randomized trial10 participantsVision Support forGinkgo
  19. Gildeuretinol Acetate versus Placebo for Geographic Atrophy Secondary to Age-Related Macular Degeneration: The Study of ALK-001 in Geographic Atrophy Randomized Clinical Trial.
    Boyer DS; Saad L; Washington I; Melamud A; Graham KB; O'Malley AE; DeBartolomeo GM; Jiang H; Harris LD; Kay CN; Ferrone PJ; Khan S; SAGA Study Team · Ophthalmology. Retina · 2026
    Randomized trial198 participantsVision Support forVitamin A
  20. [Treatment of choroidal neovascularization with Chinese medicine huangban bianxing recipe].
    Jin M; Zhang YH; Qiu YN · Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine · 2010
    Non-randomized trial80 participantsVision Support forGinkgo
  21. Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy.
    Owsley C; McGwin G; Jackson GR; Heimburger DC; Piyathilake CJ; Klein R; White MF; Kallies K · Investigative ophthalmology & visual science · 2006
    Randomized trial104 participantsVision Support forVitamin A
  22. Phytochemicals and age-related eye diseases.
    Rhone M; Basu A · Nutrition reviews · 2009
    Narrative reviewVision Support forGinkgo
  23. Dietary Nutrient Intake and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2.
    Agrón E; Mares J; Clemons TE; Swaroop A; Chew EY; Keenan TDL; AREDS and AREDS2 Research Groups · Ophthalmology · 2021
    Cohort study8,242 participantsVision Support forVitamin A
  24. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  25. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  26. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health forGinkgo
  27. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health forGinkgo
  28. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  29. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  30. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support forGinkgo
  31. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  32. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  33. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  34. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  35. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  36. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  37. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  38. Systemic and skin-targeting beneficial effects of lycopene-enriched ice cream: A pilot study.
    Chernyshova MP; Pristenskiy DV; Lozbiakova MV; Chalyk NE; Bandaletova TY; Petyaev IM · Journal of dairy science · 2019
    Randomized trialSkin Health forLycopene
  39. Topical lycopene emulgel significantly improves biophysical parameters of human skin.
    Sohail M; Muhammad Faran Ashraf Baig M; Akhtar N; Chen Y; Xie B; Li B · European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2022
    Clinical trialSkin Health forLycopene
  40. Supplementation with tomato-based products increases lycopene, phytofluene, and phytoene levels in human serum and protects against UV-light-induced erythema.
    Aust O; Stahl W; Sies H; Tronnier H; Heinrich U · International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition · 2005
    Randomized trialSkin Health forLycopene
  41. Association of Vitamin A Intake With Cutaneous Squamous Cell Carcinoma Risk in the United States.
    Kim J; Park MK; Li WQ; Qureshi AA; Cho E · JAMA dermatology · 2024
    Cohort study123,570 participantsSkin Health forLycopene
  42. β-Carotene and other carotenoids in protection from sunlight.
    Stahl W; Sies H · The American journal of clinical nutrition · 2013
    Narrative reviewSkin Health forLycopene
  43. Efficacy and Tolerability of Topical 0.1% Stabilized Bioactive Retinol for Photoaging: A Vehicle-Controlled Integrated Analysis.
    Farris P; Berson D; Bhatia N; Goldberg D; Lain E; Mariwalla K; Zeichner J; Miller D; McGuire T; Kizoulis M · Journal of drugs in dermatology : JDD · 2024
    Meta-analysis471 participants6 studies pooledSkin Health forVitamin A
  44. Tensile properties and contours of aging facial skin. A controlled double-blind comparative study of the effects of retinol, melibiose-lactose and their association.
    Piérard-Franchimont C; Castelli D; Cromphaut IV; Bertin C; Ries G; Cauwenbergh G; Piérard GE · Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2016
    Randomized trial120 participantsSkin Health forVitamin A
  45. Antiaging action of retinol: from molecular to clinical.
    Bellemère G; Stamatas GN; Bruère V; Bertin C; Issachar N; Oddos T · Skin pharmacology and physiology · 2009
    Randomized trial48 participantsSkin Health forVitamin A
  46. An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer.
    Balado-Simó P; Morgado-Carrasco D; Gómez-Armayones S; López-Ferrer A; Barco D; Ferrándiz-Pulido C; Podlipnik S · Journal of clinical medicine · 2025
    Narrative reviewSkin Health forVitamin A
  47. Novel Cyclized Hexapeptide-9 Outperforms Retinol Against Skin Aging: A Randomized, Double-Blinded, Active- and Vehicle-Controlled Clinical Trial.
    Chang H; Tao K; Yang Y; Wang Y; Ge M; Wang X; Tang S; Yu H · Journal of cosmetic dermatology · 2025
    Randomized trialSkin Health forVitamin A
  48. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  49. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo